Bijuva

Active Ingredient(s): Estradiol + Progesterone
FDA Approved: * October 28, 2018
Pharm Company: * THERAPEUTICSMD INC
Category: Women's Health / Fertility

Estradiol/progesterone (E2/P4), sold under the brand names Bijuva and Juvenum, is a combined estrogen and progestogen medication which is used in the treatment of menopausal symptoms in postmenopausal women.[1] It contains estradiol, an estrogen, and progesterone, a progestogen, and is available in both oral and intramuscular formulations.[1] E2/P4 differs from other estrogen–progestogen formulations in that the sex-hormonal agents used are bioidentical. ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bijuva Oral Capsule
NDC: 50261-211
Labeler:
Therapeuticsmd, Inc.
Bijuva Oral Capsule
NDC: 50261-251
Labeler:
Therapeuticsmd, Inc.
Bijuva Oral Capsule
NDC: 68308-750
Labeler:
Mayne Pharma
Bijuva Oral Capsule
NDC: 68308-751
Labeler:
Mayne Pharma